Bacil Pharma [BACPHAR] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Bacil Pharma Ltd.

BSE
Loading...

Sun Pharma Advanced Research Company Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Bacil Pharma Ltd. wins in 8 metrics, Sun Pharma Advanced Research Company Ltd. wins in 8 metrics, with 1 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric Bacil Pharma Ltd. Sun Pharma Advanced Research Company Ltd. Better
P/E Ratio (TTM) 118.00 -13.65 Bacil Pharma Ltd.
Price-to-Book Ratio 3.09 -13.55 Bacil Pharma Ltd.
Debt-to-Equity Ratio 0.00 -1.21 Tie
PEG Ratio -0.91 -11.15 Bacil Pharma Ltd.
EV/EBITDA -312.09 -22.27 Sun Pharma Advanced Research Company Ltd.
Profit Margin (TTM) 134.64% -53.22% Bacil Pharma Ltd.
Operating Margin (TTM) -39.22% -700.71% Bacil Pharma Ltd.
Return on Equity 1.59% 157.88% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) 1.58% -102.08% Bacil Pharma Ltd.
Free Cash Flow (TTM) $4.01M $-3.71B Bacil Pharma Ltd.
1-Year Return 10.61% 34.88% Sun Pharma Advanced Research Company Ltd.
Price-to-Sales Ratio (TTM) 154.56 87.98 Sun Pharma Advanced Research Company Ltd.
Enterprise Value $754.34M $50.87B Sun Pharma Advanced Research Company Ltd.
EV/Revenue Ratio 137.68 95.73 Sun Pharma Advanced Research Company Ltd.
Gross Profit Margin (TTM) N/A -59.53% N/A
Revenue per Share (TTM) $0 $2 Sun Pharma Advanced Research Company Ltd.
Earnings per Share (Diluted) $0.50 $-8.25 Bacil Pharma Ltd.
Beta (Stock Volatility) 0.55 0.19 Sun Pharma Advanced Research Company Ltd.

Bacil Pharma Ltd. vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis

Loading Price Chart...

BACPHAR
SPARC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bacil Pharma Ltd.-9.98%-20.59%-30.97%-19.51%0.92%5.05%
Sun Pharma Advanced Research Company Ltd.2.36%12.49%39.95%100.62%67.89%69.61%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bacil Pharma Ltd.10.61%366.06%494.15%1,158.50%1,113.06%494.15%
Sun Pharma Advanced Research Company Ltd.34.88%14.54%-3.55%-20.47%148.26%-23.02%

Performance & Financial Health Analysis: Bacil Pharma Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricBACPHARSPARC
Market Information
Market Cap i₹804.20M₹46.75B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i5,5802,401,062
90 Day Avg. Volume i15,2932,083,443
Last Close₹39.31₹229.03
52 Week Range₹26.69 - ₹61.80₹108.00 - ₹248.75
% from 52W High-36.39%-7.93%
All-Time High₹62.56 (Dec 16, 2024)₹875.00 (Apr 24, 2006)
% from All-Time High-37.16%-73.83%
Growth Metrics
Quarterly Revenue GrowthN/A-0.43%
Quarterly Earnings GrowthN/A-0.43%
Financial Health
Profit Margin (TTM) i1.35%-0.53%
Operating Margin (TTM) i-0.39%-7.01%
Return on Equity (TTM) i0.02%1.58%
Debt to Equity (MRQ) i0.00-1.21
Cash & Liquidity
Book Value per Share (MRQ)₹19.09₹-10.63
Cash per Share (MRQ)₹1.22₹0.03
Operating Cash Flow (TTM) i₹3.94M₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹4.04M₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Bacil Pharma Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricBACPHAR (Apr 24, 2026)SPARC (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i118.00-13.65
Forward P/E iN/A2.60
PEG Ratio i-0.91-11.15
Price to Sales (TTM) i154.5687.98
Price to Book (MRQ) i3.09-13.55
Market Capitalization
Market Capitalization i₹804.20M₹46.75B
Enterprise Value i₹754.34M₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i137.6895.73
Enterprise to EBITDA i-312.09-22.27
Risk & Other Metrics
Beta i0.550.19
Book Value per Share (MRQ) i₹19.09₹-10.63

Financial Statements Comparison: Bacil Pharma Ltd. vs Sun Pharma Advanced Research Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBACPHAR (2025)SPARC (2025)
Revenue/Sales i0717.66M
Cost of Goods Sold i01.10B
COGS % of Revenue i-153.2%
Gross Profit i0-381.94M
Gross Margin i--53.2%
Research & Development iN/AN/A
Operating Income (EBIT) i-1.87M-3.34B
Operating Margin i--465.5%
EBITDA i-1.29M-3.23B
EBITDA Margin i--450.0%
Pre-Tax Income i4.08M-3.43B
Pre-Tax Income % of Revenue i--477.6%
Income Tax i34,460-2.72M
Income Tax % of Revenue i--0.4%
Net Income (Profit) i4.04M-3.43B
Profit Margin i--477.3%

Balance Sheet & Liquidity Metrics

MetricBACPHAR (2025)SPARC (2025)
Cash & Equivalents i28.57M19.64M
Total Current Assets i29.07M261.97M
Total Current Assets % of Revenue i-36.5%
Total Current Liabilities i1.69M3.74B
Total Current Liabilities % of Revenue i-521.5%
Long-Term Debt iN/A1.07B
Long-Term Debt % of Revenue i-149.0%
Total Shareholders Equity i254.31M-2.17B
Retained Earnings i114.61M-23.22B
Retained Earnings % of Revenue i--3,235.0%
Property, Plant & Equipment iN/A178.02M

Cash Flow Statement Comparison

MetricBACPHAR (2025)SPARC (2025)
Operating Cash Flow i3.94M-3.48B
Operating Cash Flow % of Revenue i--485.5%
Capital Expenditures i0-97.45M
Free Cash Flow i4.01M-3.71B
FCF Margin i--516.4%
Debt Repayment iN/A-3.69B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBACPHARSPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i14.35M324.52M
Float Shares i3.93M91.32M
% Held by Insiders i81.03%72.96%
% Held by Institutions i0.00%2.56%
% Held by Public i18.97%24.48%

Dividend Analysis & Yield Comparison: Bacil Pharma Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricBACPHARSPARC
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A